TCIM
RNAC icon

TIAA CREF Investment Management’s Cartesian Therapeutics RNAC Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2019
Q1
$74K Hold
31,333
﹤0.01% 2977
2018
Q4
$83K Hold
31,333
﹤0.01% 2975
2018
Q3
$487K Sell
31,333
-1,945
-6% -$30.2K ﹤0.01% 2725
2018
Q2
$441K Sell
33,278
-3,754
-10% -$49.7K ﹤0.01% 2843
2018
Q1
$377K Buy
37,032
+3,660
+11% +$37.3K ﹤0.01% 2848
2017
Q4
$327K Sell
33,372
-5,091
-13% -$49.9K ﹤0.01% 2925
2017
Q3
$702K Sell
38,463
-3,344
-8% -$61K ﹤0.01% 2678
2017
Q2
$830K Buy
41,807
+36,674
+714% +$728K ﹤0.01% 2635
2017
Q1
$74K Buy
5,133
+350
+7% +$5.05K ﹤0.01% 3056
2016
Q4
$82K Buy
+4,783
New +$82K ﹤0.01% 3092